Abstract
This paper reviews a series of 246 patients with Hodgkin's disease treated in the Royal Air Force Medical Service between 1940 and 1966. The clinical and histological staging of the disease in relation to the survival time is evaluated. The variation in the clinical patterns of the disease, together with the histological appearances in the affected glands, can be related to the patient's defence system. A most important clinical factor in assessing prognosis is considered to be the presence or absence of constitutional symptoms. The majority of the patients who had constitutional symptoms on presentation also had many glands involved. It was found in those patients who had no constitutional symptoms at the onset of the disease that there was little difference in survival time between those with glands involved in a single group or region and those with glands involved in many regions, whether above and/or below the diaphragm. Those patients with histologically well differentiated lesions showed a significantly higher survival rate than those in the histologically poorly differentiated groups.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Binns J. H., Southall A. C. Intensive cyclophosphamide therapy in advanced malignant disease. Practitioner. 1970 Apr;204(222):546–548. [PubMed] [Google Scholar]
- Cross R. M. Hodgkin's disease: histological classification and diagnosis. J Clin Pathol. 1969 Mar;22(2):165–182. doi: 10.1136/jcp.22.2.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HANSON T. A. HISTOLOGICAL CLASSIFICATION AND SURVIVAL IN HODGKIN'S DISEASE; A STUDY OF 251 CASES WITH SPECIAL REFERENCE TO NODULAR SCLEROSING HODGKIN'S DISEASE. Cancer. 1964 Dec;17:1595–1603. doi: 10.1002/1097-0142(196412)17:12<1595::aid-cncr2820171212>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
- Kaplan H. S., Rosenberg S. A. Extended-field radical radiotherapy in advanced Hodgkin's disease: short-term results of 2 randomized clinical trials. Cancer Res. 1966 Jun;26(6):1268–1276. [PubMed] [Google Scholar]
- LUKES R. J. RELATIONSHIP OF HISTOLOGIC FEATURES TO CLINICAL STAGES IN HODGKIN'S DISEASE. Am J Roentgenol Radium Ther Nucl Med. 1963 Nov;90:944–955. [PubMed] [Google Scholar]
- Lukes R. J., Butler J. J. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1063–1083. [PubMed] [Google Scholar]
- PETERS M. V., MIDDLEMISS K. C. A study of Hodgkin's disease treated by irradiation. Am J Roentgenol Radium Ther Nucl Med. 1958 Jan;79(1):114–121. [PubMed] [Google Scholar]
- Peters M. V. Prophylactic treatment of adjacent areas in Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1232–1243. [PubMed] [Google Scholar]
- Rappaport H., Strum S. B. Vascular invasion in Hodgkin's disease: its incidence and relationship to the spread of the disease. Cancer. 1970 Jun;25(6):1304–1313. doi: 10.1002/1097-0142(197006)25:6<1304::aid-cncr2820250608>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
- Symmers W. S., Sr Survey of the eventual diagnosis in 600 cases referred for a second histological opinion after an initial biopsy diagnosis of Hodgkin's disease. J Clin Pathol. 1968 Sep;21(5):650–653. doi: 10.1136/jcp.21.5.650. [DOI] [PMC free article] [PubMed] [Google Scholar]